Page URL:

Young stem cells isolated from old mice

26 October 2020
Appeared in BioNews 1069

An innovative method of isolating 'young' stem cells still present in old mice has been developed during a study that also highlights how the activity of mitochondria plays a central role in stem cell 'fitness' rather than age.

According to a collaborative study between Lund Stem Cell Centre, Sweden and University College London, there is clinical potential of targeting mitochondrial activity for the treatment of age associated blood disease. Ageing leads to a decrease in blood stem cells' ability to produce adequate levels of mature blood cells. This can lead to an increased risk of blood disorders such as anaemia and cancer.

'We began by comparing the mitochondrial activity of stem cells from old and young mice.' explains Dr Els Mansell, a postdoctoral researcher and first author of the study. 'To do this we looked at mitochondrial membrane potential, MMP for short, reflecting the electrical potential and proton gradient of mitochondria.'

The study presents a conceptualised view on ageing in two forms: chronological age and physiological age. The former, referring to the actual age of the organism, hence all stem cells within an organism will share the same chronological age. Physiological age refers to an age-linked performance characteristic. Thus, cells that share the same chronological age could have different physiological ages.

The study, published in Cell Stem Cell, revealed, there is a general decrease in mitochondrial activity of stem cells with age but they did discover a small population of (chronologically) aged stem cells that had an MMP similar to that of young stem cells. This population of old stem cells exhibited a gene expression profile that was very similar to that of young stem cells.

'We then performed transplantation studies with stem cells isolated from aged mice treated with mitoquinol (mito-Q), a drug that increases MMP,' explains Dr Mansell.

The treated mito-Q, aged stem cells, behave like young stem cells. The researchers speculate the clinical possibility of targeting mitochondrial activity for the treatment of age related blood disease. Supplementation with mito-Q, in both middle aged and old mice, could prevent, and even reverse, the imbalance of mature blood cells and anaemia associated with ageing.

'Our findings prove that MMP is a novel indicator of the physiological age of stem cells, regardless if they are from young or old mice, and importantly, that the MMP of stem cells is a novel therapeutic target that can directly impact stem cell function,' concluded Dr Mansell.

Mitochondrial potentiation ameliorates age-related heterogeneity in haematopoietic stem cell function
Cell Stem Cell |  20 October 2020
Novel approach identifies 'young' stem cells in old mice
Lund Stem Cell Centre |  20 October 2020
‘Young’ stem cells identified in old mice using a new approach
RegMedNet |  22 October 2020
7 December 2020 - by Dr Emma Green 
Development of a new 'intermediate' embryonic stem cell type, able to generate gamete cells and chimeras, could lead to advances in regenerative medicine and reproductive biology...
30 March 2020 - by Dr Molly Godfrey 
Researchers have returned stem cells from older donors to a more youthful biological state...
24 September 2018 - by Shaoni Bhattacharya 
Scientists have found sources of skeletal stem cells in humans for the first time...
19 December 2016 - by Sarah Gregory 
Gene therapy can reverse the effects of ageing in mice, researchers claim...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.